Graduated from Peking Union Medical College in 2016 with a Doctor of Surgery degree. Since graduation, has been working at Peking University Cancer Hospital, successively serving as Chief Resident, Attending Physician, and Associate Chief Physician in the First Ward of the Gastrointestinal Tumor Center. Specializes in surgical treatment and perioperative comprehensive management of gastrointestinal tumors, including gastric cancer, esophagogastric junction cancer, colon cancer, rectal cancer, and gastrointestinal stromal tumors. In clinical practice, consistently upholds humanistic care, practices benevolent medicine, and treats every patient with dedication. Through long-term frontline clinical work, has accumulated extensive experience and received consistent praise from patients. In research, the main focus is on neoadjuvant chemotherapy for gastric cancer, function-preserving surgery for gastric cancer, and nutritional metabolism of gastrointestinal malignancies. In 2021, participated as the primary investigator in the Beijing Cultivation Program's Clinical Technology Innovation Project, "Monitoring and Clinical Application of Immune Status in Preoperative Chemotherapy for Gastric Cancer." Served as the lead author in drafting the "Chinese Expert Consensus on Perioperative Nutritional Therapy for Gastric Cancer." Based on nutritional therapy, explored the implementation of enhanced recovery after surgery (ERAS) in the perioperative period of gastric cancer and authored the "Implementation Strategies for Enhanced Recovery After Surgery in Gastric Cancer Perioperative Care." In 2019, received the Science Popularization Award in the 18th "Health Good News" competition of the Beijing Health System. In 2022, was selected for the Beijing Science and Technology Association's Young Talent Support Program.